Dow’s 7 underperformers—time to buy?

Of the 30 stocks on the Dow, 23 have hit 52-week highs this year.

That means only seven have not: NikeGeneral ElectricWal-MartIBMProcter & GambleVerizon and Cisco.

Noah Blackstein, vice president and portfolio manager of Dynamic Funds, is not betting they’ll catch up.

Read More This is driving the market’s gains this year

For a lot of the companies, “there really are fundamental reasons which are driving their underperformance,” he told CNBC’s “Power Lunch” on Monday.

Getty Images

Getty Images

Instead, he has his eye on small- and mid-cap stocks.

“As the U.S. economy continues to pick up steam and interest rates move higher, the smaller caps and the mid-caps are going to start to gain on the larger-cap companies,” Blackstein said.

Read More Dow, S&P headed to this level: Art Cashin

He likes and Biogen Idec.

However, Allianz Global Investors’ Kristina Hooper believes the avoidance of large-cap stocks is unfortunate because they can offer good dividends.

“If investors have a long enough time horizon, they should have adequate exposure to large caps,” she said.

Read More Mutual fund pro: Don’t fight ‘wrong’ Fed policies

“It looks like small caps will continue to outperform this year and that’s largely because of the monetary policy backdrop but at a certain point that will go away. The Fed will become less accommodative and the investing landscape may return to a more normal environment,” she added.

Hooper likes financials, oil producers and selective tech names, calling them “attractively valued.”

—By CNBC’s Michelle Fox. CNBC’s Jennet Chin contributed to this report.

Disclosure: Noah Blackstein owns and Biogen Idec in his portfolio.

This entry was posted in Stocks. Bookmark the permalink.

Leave a Reply